India · Delayed Price · Currency is INR SMS Pharmaceuticals Statistics
Total Valuation
NSE:SMSPHARMA has a market cap or net worth of INR 35.72 billion. The enterprise value is 38.91 billion.
| Market Cap | 35.72B |
| Enterprise Value | 38.91B |
Important Dates
The last earnings date was Friday, May 22, 2026.
| Earnings Date | May 22, 2026 |
| Ex-Dividend Date | Sep 22, 2025 |
Share Statistics
NSE:SMSPHARMA has 93.65 million shares outstanding. The number of shares has increased by 3.18% in one year.
| Current Share Class | 93.65M |
| Shares Outstanding | 93.65M |
| Shares Change (YoY) | +3.18% |
| Shares Change (QoQ) | +0.83% |
| Owned by Insiders (%) | 64.29% |
| Owned by Institutions (%) | 3.23% |
| Float | 23.32M |
Valuation Ratios
The trailing PE ratio is 34.21.
| PE Ratio | 34.21 |
| Forward PE | n/a |
| PS Ratio | 3.99 |
| PB Ratio | 4.55 |
| P/TBV Ratio | 4.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 60.32 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.10, with an EV/FCF ratio of -54.55.
| EV / Earnings | 38.15 |
| EV / Sales | 4.35 |
| EV / EBITDA | 20.10 |
| EV / EBIT | 25.32 |
| EV / FCF | -54.55 |
Financial Position
The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.46.
| Current Ratio | 1.81 |
| Quick Ratio | 0.74 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | 2.03 |
| Debt / FCF | -5.12 |
| Interest Coverage | 6.05 |
Financial Efficiency
Return on equity (ROE) is 14.31% and return on invested capital (ROIC) is 10.60%.
| Return on Equity (ROE) | 14.31% |
| Return on Assets (ROA) | 6.94% |
| Return on Invested Capital (ROIC) | 10.60% |
| Return on Capital Employed (ROCE) | 13.84% |
| Weighted Average Cost of Capital (WACC) | 6.30% |
| Revenue Per Employee | 6.09M |
| Profits Per Employee | 693,803 |
| Employee Count | 1,470 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 1.84 |
Taxes
In the past 12 months, NSE:SMSPHARMA has paid 286.40 million in taxes.
| Income Tax | 286.40M |
| Effective Tax Rate | 21.92% |
Stock Price Statistics
The stock price has increased by +45.32% in the last 52 weeks. The beta is 0.40, so NSE:SMSPHARMA's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +45.32% |
| 50-Day Moving Average | 401.68 |
| 200-Day Moving Average | 321.75 |
| Relative Strength Index (RSI) | 41.17 |
| Average Volume (20 Days) | 339,141 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:SMSPHARMA had revenue of INR 8.95 billion and earned 1.02 billion in profits. Earnings per share was 11.15.
| Revenue | 8.95B |
| Gross Profit | 3.11B |
| Operating Income | 1.40B |
| Pretax Income | 1.31B |
| Net Income | 1.02B |
| EBITDA | 1.80B |
| EBIT | 1.40B |
| Earnings Per Share (EPS) | 11.15 |
Balance Sheet
The company has 460.75 million in cash and 3.65 billion in debt, with a net cash position of -3.19 billion or -34.06 per share.
| Cash & Cash Equivalents | 460.75M |
| Total Debt | 3.65B |
| Net Cash | -3.19B |
| Net Cash Per Share | -34.06 |
| Equity (Book Value) | 7.86B |
| Book Value Per Share | 85.99 |
| Working Capital | 2.85B |
Cash Flow
In the last 12 months, operating cash flow was 592.24 million and capital expenditures -1.31 billion, giving a free cash flow of -713.35 million.
| Operating Cash Flow | 592.24M |
| Capital Expenditures | -1.31B |
| Depreciation & Amortization | 399.19M |
| Net Borrowing | 540.72M |
| Free Cash Flow | -713.35M |
| FCF Per Share | -7.62 |
Margins
Gross margin is 34.76%, with operating and profit margins of 15.61% and 11.39%.
| Gross Margin | 34.76% |
| Operating Margin | 15.61% |
| Pretax Margin | 14.59% |
| Profit Margin | 11.39% |
| EBITDA Margin | 20.07% |
| EBIT Margin | 15.61% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 0.10%.
| Dividend Per Share | 0.40 |
| Dividend Yield | 0.10% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 3.48% |
| Buyback Yield | -3.18% |
| Shareholder Yield | -3.07% |
| Earnings Yield | 2.85% |
| FCF Yield | -2.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 17, 2015. It was a forward split with a ratio of 10.
| Last Split Date | Dec 17, 2015 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |